Attention deficit hyperactivity disorder - Medications and their Dangerous Side-Effects. Description: An in-depth report on the causes, ...
A PSYCHOLOGICAL FORMULATION OF MENTAL DISTRESS - THE HPP MODEL COMMENTARY - (TRAXSON, PARKER, ROWLAND AND MATTHEWS 2011)-------"What we need as professionals is a naturalistic narrative of needs NOT a dysfunctional discussion of dubiously diagnosed disorders." - A menu of alternatives to medication is proposed to trigger creative thinking about the options available to deal with behavioural difficulties.THE HPP MODEL OF MENTAL HEALTH AND WELLBEING FOR YOUNG PEOPLE FEATURES OF THE HPP MODEL - A multi-dimensional discursive appro...
DSM5, PSYCHIATRY and MEDICAL ETHICS : Is using psychotropics for normal behavioural patterns in kids + social control unethical! The Stanford University 4 key principles are clearly breached in the U.S. and the U.K.for children on psychotropic drugs - unethical practice is the 'trump card' in the campaign against the influence of DSM5 and the safeguarding of our children in the U.K.and the U.S. - Let's deal our children a better hand!-Map of U.S. showing skewed prescription rate for ADHD - (low prescription use in west, with the sun and surf outlets, and higher across ...
PLEASE SIGN THIS IMPORTANT PETITION TO THE DEPARTMENT OF HEALTH - We request an urgent review by the DoH of the use of Risperidone with young boys identified on the autistic spectrum.PLEASE CLICK ON THE LINK BELOW TO SIGN THE PETITION - LINK: https://you.38degrees.org.uk/petitions/an-urgent-review-of-the-pr...
Why No One Is Satisfied With Psychiatric Diagnoses Main Category: Psychology / Psychiatry The Diagnostic and Statistical Manual of Me...
Many authors of psychiatry bible have industry ties 21:00 13 March 2012 by ...
THE MENTAL HEALTH DEBATE = A GREAT ARTICLE - "At War With Ourselves"- By Rufus May, a Psychologist from Bradford U.K. - Courtesy of Mad in America WebsiteAt War With Ourselves Rufus May September 15, 2013 If we call someone mentally ill, in some ways we may b...
DR ALLEN FRANCES (LEAD EDITOR OF THE DSM4 PANEL) - COINS THE TERM - 'FALSE EPIDEMICS OF CHILDHOOD DISORDERS' DUE TO DSM4.DR ALLAN FRANCES ADMITS: " WE MADE MISTAKES WITH DSM4 WHICH HAVE HAD TERRIBLE CONSEQUENCES FOR CHILDREN.&quo...
Total Downloads Worldwide
Saturday, 10 September 2016
BMJ STUDY - Most Anti-depressants don't work on teens or kids - By Kimberly Leonard
Prescribing antidepressants to children and teens appears to be ineffective at best and can increase the risk of suicide among users, leading authors of a new study to conclude that the drugs do "not seem to offer a clear advantage."
The analysis, published Wednesday in the British medical journal The Lancet, examined 14 antidepressants given to young people in various randomized trials conducted through May 2015. Fluoxetine – widely known as Prozac and the most commonly prescribed medication for young people with depression in the United Kingdom – was the only drug found to be effective at relieving the symptoms of depression. Sertraline, known as Zoloft, was the most commonly prescribed antidepressant in the U.S., but it was not the one found to be the most effective in relieving the symptoms of depression.
The most severe side effects were associated with venlafaxine, or Effexor, which was linked with an increased risk of having suicidal thoughts and attempts, compared with a placebo and with five other antidepressants.
The increased risk of suicide because of certain antidepressants has already been recognized. In 2004, the U.S. Food and Drug Administration placed a black box warning on antidepressants for those under 24 years old, after evidence suggested a suicide link. These medications are used to treat commonly diagnosed cases of "major depressive disorder," which affects roughly 3 percent of children and 6 percent of adolescents.
Along with Effexor, other drugs evaluated – including Imipramine, which is known as Tofranil, and duloxetine, known as Cymbalta – had the highest chance of being discontinued by patients, who reported that they did so because they couldn't tolerate their side effects. The study didn't go into what the specific side effects were, but the FDA has listed a few, including weight gain, anxiety or changes in sex drive, depending on the drug.
The Lancet analysis involved 34 trials and 5,260 young participants, and authors warned that data likely were underestimating adverse events, including suicide. They also noted that many of the clinical trials they relied on for evaluating antidepressants were funded by drug companies, which can result in poorly designed trials and in selective reporting of findings.
In an accompanying comment, Dr. Jon Jureidini from the University of Adelaide in Australia questioned whether more suicidal events would have been reported if the data had been more reliable. For instance, he cites that in trials of the drug paroxetine – most commonly known as Paxil – 3 percent of adverse events were reported, but individual patient-level data has revealed an incidence closer to 11 percent.
He wrote that there was "little reason to think that any antidepressant is better than nothing for young people."
"Prescribing might help the doctor feel like he or she is doing something, or help parents feel that something is being done, but the adolescent might feel it to be dismissive of their distress," he wrote.
One of the co-authors of the study, Prof. Peng Xie from The First Affiliated Hospital of Chongqing Medical University in Chongqing, took a more measured approach, saying that children should be monitored closely regardless of the antidepressant prescribed.